# Galvani Bioelectronics

its splenic neuromodulation therapy for rheumatoid arthritis received FDA approval to progress to the randomized, controlled stage of clinical feasibility testing, alongside a new Chief Medical Officer appointment.

Source: https://en.bioecon.ru/companies/galvani-bioelectronics/
Updated: 2026-07-20

- Country: United Kingdom

## Technologies

- [Bioelectronic medicine & neuromodulation](https://en.bioecon.ru/technology/bioelectronic-medicine-neuromodulation/)